Back
44
Day Range
$493.60
$502.13
52-Week Range
$314.43
$556.52
Volume
1,274,788
50D / 200D Avg
$508.95
/
$443.17
Prev Close
$493.88
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 16.3 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | 9.0 | 3.8 |
| Rev Growth 5Y % | 6.5 | 10.0 |
| D/E | — | 0.2 |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 11, 2026 |
Berres Jennifer
SVP & Chief Human Res. Officer
|
sell | 8,020 | $503.00 | $4,126,950 |
| Feb 10, 2026 |
Berres Jennifer
SVP & Chief Human Res. Officer
|
other | 2,515 | $502.05 | $1,262,656 |
| Feb 10, 2026 |
Berres Jennifer
SVP & Chief Human Res. Officer
|
grant | 7,116 | — | — |
| Feb 6, 2026 |
FRIST THOMAS F III
|
other | 73,186,329 | — | — |
| Feb 6, 2026 |
Frisco Holding II
|
other | 73,186,329 | — | — |
| Feb 6, 2026 |
Elcan Patricia F
|
other | 73,186,329 | — | — |
| Feb 6, 2026 |
HERCULES HOLDING II
|
other | 36,629,188 | — | — |
| Feb 6, 2026 |
Frist William R
|
other | 73,186,329 | — | — |
| Feb 6, 2026 |
FRIST THOMAS F JR
|
other | 73,186,329 | — | — |
| Feb 4, 2026 |
HAZEN SAMUEL N
CEO
|
other | 2,090 | $498.35 | $1,041,552 |
| Feb 3, 2026 |
HAZEN SAMUEL N
CEO
|
sell | 42,877 | $502.95 | $21,483,275 |
| Jan 29, 2026 |
McAlevey Michael R
EVP & Chief Legal & Admin Off.
|
grant | 8,067 | — | — |
| Jan 29, 2026 |
Marks Mike A
EVP and CFO
|
grant | 11,945 | — | — |
| Oct 31, 2025 |
HAZEN SAMUEL N
CEO
|
other | 144,273 | $69.58 | — |
| May 13, 2025 |
Foster Jon M
EVP and COO
|
other | 38,160 | — | — |
| May 13, 2025 |
Foster Jon M
EVP and COO
|
sell | 15,698 | $369.32 | $5,797,661 |
| Apr 30, 2025 |
Frist William R
|
other | 10,505 | $340.60 | $3,578,003 |
| Apr 29, 2025 |
FRIST THOMAS F III
|
grant | 1,320 | — | — |
| Apr 29, 2025 |
MICHELSON MICHAEL W
|
grant | 1,173 | — | — |
| Apr 29, 2025 |
Frist William R
|
grant | 1,026 | — | — |
Key Takeaways
Revenue grew 6.51% annually over 5 years — modest growth
Earnings grew 17.78% over the past year
Generating 7.69B in free cash flow
PEG of 0.56 suggests growth is underpriced
Cash machine — converts 113.38% of earnings into free cash flow
Capital efficient — spends only 6.54% of revenue on capex
Growth
Revenue Growth (5Y)
6.51%
Revenue (1Y)7.08%
Earnings (1Y)17.78%
FCF Growth (3Y)28.11%
Quality
Return on Equity
N/A
ROIC20.32%
Net Margin8.97%
Op. Margin15.83%
Safety
Debt / Equity
N/A
Current Ratio0.83
Interest Coverage5.32
Valuation
P/E Ratio
16.30
P/B RatioN/A
EV/EBITDA13.35
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.08% | Revenue Growth (3Y) | 7.87% |
| Earnings Growth (1Y) | 17.78% | Earnings Growth (3Y) | 13.76% |
| Revenue Growth (5Y) | 6.51% | Earnings Growth (5Y) | -0.62% |
| Profitability | |||
| Revenue (TTM) | 75.60B | Net Income (TTM) | 6.78B |
| ROE | N/A | ROA | 11.17% |
| Gross Margin | 41.50% | Operating Margin | 15.83% |
| Net Margin | 8.97% | Free Cash Flow (TTM) | 7.69B |
| ROIC | 20.32% | FCF Growth (3Y) | 28.11% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.83 |
| Interest Coverage | 5.32 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 16.30 | P/B Ratio | N/A |
| P/S Ratio | 1.46 | PEG Ratio | 0.56 |
| EV/EBITDA | 13.35 | Dividend Yield | 0.01% |
| Market Cap | 110.60B | Enterprise Value | 159.76B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 75.60B | 70.60B | 64.97B | 60.23B | 58.75B |
| Net Income | 6.78B | 5.76B | 5.24B | 5.64B | 6.96B |
| EPS (Diluted) | 28.38 | 22.00 | 18.96 | 19.15 | 21.16 |
| Gross Profit | 31.37B | 28.68B | 25.58B | 23.18B | 22.49B |
| Operating Income | 11.97B | 10.55B | 9.63B | 9.05B | 9.68B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 60.72B | 59.51B | 56.21B | 52.44B | 50.74B |
| Total Liabilities | 63.49B | 58.96B | 55.15B | 52.51B | 49.25B |
| Shareholders' Equity | -6.03B | -2.50B | -1.77B | -2.77B | -933.00M |
| Total Debt | 50.20B | 45.24B | 41.86B | 40.20B | 36.73B |
| Cash & Equivalents | 1.04B | 1.93B | 935.00M | 908.00M | 1.45B |
| Current Assets | 13.56B | 16.41B | 14.93B | 13.64B | 13.54B |
| Current Liabilities | 16.35B | 15.18B | 12.66B | 9.90B | 9.58B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#216 of 326
Recent Activity
Entered
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026